期刊文献+

贝伐单抗与希罗达联用可有效治疗转移性结直肠癌 被引量:1

下载PDF
导出
摘要 罗氏制药公司近日宣布,2035例此前未经治疗的转移性直肠癌患者被征集参加大型国际第Ⅲ期试验(N016966)达到两个主要终点的要求。
作者 刘巧俏
出处 《国外医学情报》 2006年第11期19-20,共2页 foreign medical information
  • 相关文献

同被引文献9

  • 1杨惠娣,倪洁.消化系统肿瘤的靶向治疗进展[J].世界临床药物,2005,26(7):418-420. 被引量:2
  • 2马冬.贝伐单抗联合依立替康、氟尿嘧啶/甲酰四氢叶酸对转移性结直肠癌的治疗[J].循证医学,2006,6(5):277-280. 被引量:6
  • 3Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solide tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [ J ]. J Natl Cancer Inst,2000 ,92 :205
  • 4Goldberg RM, Sargent DJ, Morton RF et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinationgs inpatients with previously untreated metastatic colorectal cancer[ J]. J Clin Oncol, 2004,22 : 23
  • 5de Gramont A, Figer A, Seymour M et al. Leucovorin and fluorouracil with or without oxaliplatin as first - line treatment in advanced colorectal cancer [ J ]. J Clin Oncol,2000,18:2938
  • 6Tournigand C, Andre T, Achille E et al. FOLFIRI followed FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study [ J ]. J Clin Oncol,2004,22 :229
  • 7Hurwitz H, Fehrenbacher L, Novotny Wet al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [ J ]. N Engl J Med, 2004, 350:2335
  • 8Giantonio B, Catalano P, Meropol Net al. High - dose Bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG) study E3200[J]. J Clin Oncol,2005, 23 (suppl) : abstract 2
  • 9李丽萍,孙丽凯.贝伐单抗联合化疗治疗结直肠癌患者的护理[J].护理学杂志,2008,23(13):65-66. 被引量:7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部